Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tipifarnib in Treating Young Patients With Refractory Leukemia

This study has been completed.
National Cancer Institute (NCI)
Children's Oncology Group
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: August 10, 2001
Last updated: March 14, 2012
Last verified: March 2012